Research Day 2022


The University of Florida Department of Surgery is honored to welcome

Dr. Andrew M. Lowy
Professor of Surgery
University of California San Diego
Chief, Division of Surgical Oncology

as the 2022 Dragstedt Visiting Professor for the 17th annual Department of Surgery Research Day which will be held on

Thursday, June 9, 2022 (5-7:30pm)

and

Friday June 10, 2022 (7-Noon)

 

in the Harrell Medical Education Building

 

Dr. Andrew M. Lowy is a surgical oncologist with a primary interest in cancers of the pancreas, liver and GI tract. He has a specialty interest in the management of patients with metastatic disease to the liver and peritoneum.

Dr. Lowy is recognized worldwide for his expertise in the surgical treatment of pancreatic cancer and for investigating novel cancer treatments which incorporate surgery and chemotherapy to treat patients with advanced cancer that has spread to the abdomen. He has furthered the development of heated intraperitoneal chemotherapy (HIPEC), to treat advanced abdominal cancers.

Dr. Lowy serves on the editorial boards of the Journal of Clinical Oncology and the Annals of Surgical Oncology . He also serves as surgical liaison to the Pancreas and Hepatobiliary Committee of the Southwest Oncology Group (SWOG), which is one of the largest National Cancer Institute cooperative groups. Recently, Dr. Lowy was selected to co-chair the National Cancer Institute’s Pancreatic Cancer Task Force which is charged with setting the direction of clinical research in pancreatic cancer in the United States. He has conducted extensive research in gastrointestinal and pancreatic cancer with funding from the National Cancer Institute.

Research Overview
His work is focused on the study of pancreatic carcinogenesis and therapy. More specifically, the study of the RON receptor tyrosine kinase and its role in disease pathogenesis and as a potential therapeutic target. He is also extensively involved in model development and testing of novel therapeutics and was among a team of researchers to develop the first genetically engineered mouse model of pancreatic cancer.

 


IMPORTANT DATES

Abstract Site Opens:  4/10/22 @ 2:00pm

Abstract Site Closes:  5/8/22 @ 11:59pm

Abstract Grading:  5/10/22 – 5/14/22

Notification of Abstract Acceptance:  Approx 5/16/22

Research Day:  6/9/22 and 6/10/22

 

Abstract Submission Site
(CLOSED)

 


 

Abstract Instructions:

DEADLINE: The deadline for abstract submissions is May 8, 2022, 11:59 PM ET. Abstracts must be submitted via the abstract submission link above and no late submissions will be accepted.

ABSTRACT SUBMISSIONS: There are no restrictions on the number of submissions you may submit. An individual can be named as first author on more than one abstract. However, an individual may be the first author on only one abstract accepted for oral or quick shot oral presentation.

  • Abstracts from the same first author not accepted for oral presentation will be potentially eligible for oral poster presentation.

CHARACTER LIMIT: There is a 150 character count limit for the title (including spaces) and a 3,000 character count limit (including spaces) for the body of the abstract (Introduction, Methods, Results, Conclusion).  Figures and tables are not allowed.

DISCLOSURES: You will be asked to complete specific disclosures in order to finalize your submission.

 

 


 

Special thanks to the University of Florida Department of Surgery Research Activities Committee for help making the annual Research Day a success:

Scott Berceli, MD, PhD
(Chairman Research Advisory Committee)

Ryan M. Thomas, MD
(Chair, Research Day 2022)

Ali Zarrinpar, MD, PhD

Gib Upchurch, MD

Phil Efron, MD

Zhihua Jiang, PhD

Shawn Larson, MD

Tyler Loftus, MD

Tiago Machuca, MD, PhD

Alicia Mohr, MD

Lyle Moldawer, PhD

Kerri O’Malley, PhD

Ashish Sharma, MBBS, PhD

Kim Wollard, PhD